Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Insmed Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
INSM
Nasdaq
2836
www.insmed.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Insmed Incorporated
Insmed Catapults 34%, Leading A Biotech Rally. But Mirum Takes A Bath.
- Aug 6th, 2026 2:12 pm
Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...
- Aug 6th, 2026 1:05 pm
Insmed Q2 Earnings Call Highlights
- Aug 6th, 2026 1:04 pm
Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales Outlook
- Aug 6th, 2026 8:56 am
Insmed (INSM) Reports Q2 Earnings: What Key Metrics Have to Say
- Aug 6th, 2026 7:30 am
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Thursday Amid Corporate Earnings Deluge
- Aug 6th, 2026 7:21 am
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
- Aug 6th, 2026 6:20 am
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
- Aug 6th, 2026 5:00 am
Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates
- Aug 5th, 2026 3:10 pm
Here’s Why Baron Health Care Fund Remains Bullish on Insmed (INSM)
- Aug 4th, 2026 8:12 am
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
- Jul 30th, 2026 4:00 pm
Insmed Incorporated’s (INSM) Commercial Acceleration Overshadows Q1 Stumble
- Jul 30th, 2026 8:23 am
Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- Jul 30th, 2026 8:00 am
EMV Capital: ProAxsis eyes COPD market breakthrough with Imperial College London study
- Jul 29th, 2026 4:03 am
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
- Jul 28th, 2026 2:58 am
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
- Jul 27th, 2026 10:36 am
Concerns Over the Pace of its Brinsupri’s Launch Hurt Insmed (INSM)
- Jul 24th, 2026 7:59 am
Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026
- Jul 23rd, 2026 5:00 am
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More
- Jul 21st, 2026 5:41 am
Is Insmed (INSM) Priced Too Richly For Its Phase 3 Progress?
- Jul 21st, 2026 12:10 am
Scroll